Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

inflammation · Mechanism Report

Does Enterobacteriaceae overgrowth drive intestinal inflammation and mucosal immune activation?

Overgrowth of Enterobacteriaceae such as Escherichia coli and Klebsiella promotes intestinal inflammation and activates the mucosal immune system.

SupportedJune 19, 202612 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Overgrowth of Enterobacteriaceae such as Escherichia coli and Klebsiella can promote intestinal inflammation and mucosal immune activation.

laying out figure…
All 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a causal relationship where blooms of Gram-negative Enterobacteriaceae trigger innate immune signaling and compromise the epithelial barrier, creating a cycle that favors their expansion. This immune activation is reflected in increased mucosal responses (for example higher secretory IgA) and clinical inflammation markers such as fecal calprotectin.

Verified conclusion

The overgrowth of Enterobacteriaceae, particularly species like Escherichia coli and Klebsiella, is strongly associated with the promotion of intestinal inflammation and the activation of the mucosal immune system. This relationship is often characterized by a self-reinforcing cycle where inflammation provides a metabolic advantage for these specific bacteria, further exacerbating the immune response.

Mechanistic pathways of inflammation

Enterobacteriaceae drive inflammation primarily through the activation of innate immune sensors.

  • TLR4 Signaling: The lipopolysaccharide (LPS) found in the outer membranes of Gram-negative bacteria like E. coli and Klebsiella acts as a potent ligand for Toll-like receptor 4 (TLR4). Activation of TLR4 triggers the NF-κB and MAPK pathways, leading to the secretion of pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α.
  • Epithelial Barrier Disruption: These bacteria can compromise the intestinal lining by degrading tight junction proteins such as ZO-1 and occludin. This increased permeability allows for bacterial translocation, which further stimulates the immune system.
  • Metabolic Niche: Inflammatory byproducts, such as nitrate, can be utilized by Enterobacteriaceae for anaerobic respiration, giving them a competitive edge over beneficial obligate anaerobes and sustaining their overgrowth.

Mucosal immune activation

The host responds to Enterobacteriaceae blooms by mobilizing mucosal defenses.

  • Secretory IgA (sIgA) Response: sIgA is the primary antibody of the mucosal immune system. In the presence of dysbiosis or pathogenic overgrowth, sIgA production typically increases as the host attempts to neutralize bacteria and prevent their adherence to the epithelial wall. Elevated fecal sIgA serves as a clinical biomarker for this active engagement.
  • Clinical Indicators: Overgrowth of Klebsiella has been specifically correlated with higher levels of fecal calprotectin, a reliable protein marker for neutrophil-mediated intestinal inflammation.

Bottom line

Enterobacteriaceae overgrowth promotes intestinal inflammation and mucosal immune activation through TLR4-mediated signaling and barrier disruption. This is clinically reflected in elevated markers such as fecal calprotectin and secretory IgA, indicating an active and potentially pathological host immune response.

References

  1. The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases — pmc.ncbi.nlm.nih.gov ↗
  2. The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases — mdpi.com ↗
  3. Total Lipopolysaccharide from the Human Gut Microbiome Silences Toll-Like Receptor Signaling — pmc.ncbi.nlm.nih.gov ↗
  4. Preventive effects of matrine on LPS-induced inflammation in RAW 264.7 cells and intestinal damage in mice through the TLR4/NF-κB/MAPK pathway. — linkinghub.elsevier.com ↗
  5. Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease. — pmc.ncbi.nlm.nih.gov ↗
  6. Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway. — linkinghub.elsevier.com ↗
  7. Cooperativity among secretory IgA, the polymeric immunoglobulin receptor, and the gut microbiota promotes host-microbial mutualism. — pmc.ncbi.nlm.nih.gov ↗
  8. POS0332 CD71 RECEPTOR APICAL EXPRESSION IN ILEUM IS RELATED WITH HIGH LEVELS OF SERUM SIgA AND ACTIVITY DISEASE IN SpA PATIENTS — linkinghub.elsevier.com ↗
  9. Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation — pmc.ncbi.nlm.nih.gov ↗
  10. Functional Abdominal Bloating Is Associated With Gut Microbiota Dysbiosis and Altered Intestinal Barrier Function: Experimental Evidence — iv.iiarjournals.org ↗
  11. Peucedanol ameliorates LPS-induced inflammation in RAW264.7 cells and CLP-induced sepsis in mice by inhibiting TLR4/myD88/NF-κB pathway — biorxiv.org ↗
  12. Macleaya cordata Extract Inhibits LPS-Induced IPEC-J2 Inflammation Through TLR4-Mediated NF-κB and MAPK Signaling Pathways — journals.sagepub.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan hs-CRP reflect low-grade systemic inflammation even within the normal range?→Plausible8 sourcesCan rs1420101 CT, rs20541 AG, and rs1801275 AG contribute to type 2 eosinophilic airway inflammation susceptibility?→